PTSD and Risk Behavior in HIV Positive Female Adolescents

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-03-31

Study Completion Date

2006-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a qualitative study using a purposive sampling methodology to interview HIV-positive female adolescents who have experienced physical and/or sexual abuse. An open-ended, in-depth interview, occurring over one to two sessions, will be conducted with each participant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Family-based HIV Prevention for Adolescent Girls

NCT00243126

HIV Infections

COMPLETED NA

Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse

NCT00220597

Alcoholism Child Abuse, Sexual Sexual Abuse +2 more

COMPLETED NA

Engaging Care for HIV-infected Adolescent Females.

NCT00489034

HIV Infection

COMPLETED

Development of a Novel HIV Risk Reduction Intervention for Abused Women

NCT02118948

Sexual Behavior

COMPLETED NA

Intervention Development for Newly Diagnosed Youth With HIV

NCT00255892

HIV

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is expected to take approximately 12 months to accrue participants and complete all the interviews. The interview will be conducted in one or two sessions and will be up to two hours in duration per session.

The study will initially be conducted at three ATN clinical sites with approximately 20 females recruited per site for a total of 60 participants. Other ATN clinical sites may be allowed to participate in the future if the study is slow to accrue.

The participants consist of English speaking women, ages 18-24 years, who acquired HIV through heterosexual intercourse or injection drug use after the age of 9 years, reported a history of sexual and/or physical abuse prior to age 18, and engaged in vaginal or anal intercourse in the 4 months prior to screening.

Approximately half of the participants will report a recent history of substance use as defined by study criteria and approximately half of the participants will report no such history.

Eligible patients will be identified and screened by the ATN research staff at the participating sites. The Protocol Chair and trained Research Assistant will conduct the open-ended qualitative interviews using an open-ended script. The interview will be audio-taped and transcribed. Prior to the open-ended script interview, participants will be asked about Posttraumatic Stress Disorder symptoms, abuse history, substance use, sexual behavior, and demographics. Responses to these questions will not be audio-taped and will be entered into the ATN 053 database by the ATN site staff.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PTSD Sexual Abuse HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 through 24 years old, inclusive, at the time of administration of the Screening Questionnaire.
* Female birth gender
* Verbal confirmation of acquisition of behaviorally-acquired HIV infection including from injection drug use (IDU) or heterosexual intercourse (vaginal, oral and/or anal) after the age of 9 years
* HIV-1 infection as documented by a positive result on any of the following licensed tests at any time: any antibody test confirmed by Western blot, HIV culture, plasma HIV-1 RNA PCR \> 1,000 copies/mL or a HIV DNA PCR
* History of physical and/or sexual abuse prior to age 18 years old documented by a Screening Questionnaire
* Voluntary vaginal and/or anal intercourse with a male within the 4 months prior to screening.
* Ability to understand and communicate in spoken English sufficient to provide informed consent and to be interviewed
* Availability of enrollment slots for the participant's assigned substance-use category at the time of the Screening Questionnaire. (Approximately half of the participants will report substance use) This will be monitored throughout the study enrollment period.
* Willingness to have the qualitative study interview audio-taped
* Willingness and ability to provide informed consent

Exclusion Criteria

* Currently suicidal or homicidal by clinician judgment
* Visibly distraught and/or visibly emotionally unstable (e.g., depressive mood, exhibiting manic, suicidal, or violent behavior);
* Visibly intoxicated or under the influence of psychoactive agents; or
* Presents as acutely ill.

Minimum Eligible Age

18 Years

Maximum Eligible Age

24 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No